- Home
- MEGL vs CDIO Comparison
MEGL vs CDIO Comparison
Compare MEGL & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEGL
- CDIO
- Stock Information
- Founded
- MEGL 2016
- CDIO 2017
- Country
- MEGL Hong Kong
- CDIO United States
- Employees
- MEGL N/A
- CDIO N/A
- Industry
- MEGL Finance: Consumer Services
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- MEGL Finance
- CDIO Health Care
- Exchange
- MEGL Nasdaq
- CDIO Nasdaq
- Market Cap
- MEGL 7.8M
- CDIO 6.8M
- IPO Year
- MEGL 2022
- CDIO N/A
- Fundamental
- Price
- MEGL $1.30
- CDIO $3.71
- Analyst Decision
- MEGL
- CDIO
- Analyst Count
- MEGL 0
- CDIO 0
- Target Price
- MEGL N/A
- CDIO N/A
- AVG Volume (30 Days)
- MEGL 41.7K
- CDIO 35.2K
- Earning Date
- MEGL 12-11-2025
- CDIO 11-14-2025
- Dividend Yield
- MEGL N/A
- CDIO N/A
- EPS Growth
- MEGL N/A
- CDIO N/A
- EPS
- MEGL N/A
- CDIO N/A
- Revenue
- MEGL $1,296,394.00
- CDIO $19,507.00
- Revenue This Year
- MEGL N/A
- CDIO $1,434.82
- Revenue Next Year
- MEGL N/A
- CDIO $4,661.91
- P/E Ratio
- MEGL N/A
- CDIO N/A
- Revenue Growth
- MEGL N/A
- CDIO N/A
- 52 Week Low
- MEGL $1.02
- CDIO $3.22
- 52 Week High
- MEGL $5.52
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- MEGL 40.09
- CDIO 44.85
- Support Level
- MEGL $1.29
- CDIO $3.58
- Resistance Level
- MEGL $1.40
- CDIO $3.99
- Average True Range (ATR)
- MEGL 0.09
- CDIO 0.30
- MACD
- MEGL -0.01
- CDIO -0.04
- Stochastic Oscillator
- MEGL 2.86
- CDIO 24.48
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.